# DNA Damage, Repair Pathways, and the Oxygen Effect
## Overview
Ionizing radiation exerts its cytotoxic effects primarily through damage to DNA. A thorough understanding of the types of DNA damage, the cellular repair pathways that respond to this damage, and the role of oxygen in modifying radiation sensitivity is fundamental to the field of radiobiology. These concepts directly inform clinical strategies such as radiation fractionation, the use of radiosensitizers, and the challenges posed by hypoxic tumors during treatment.
## Mechanisms of Radiation-Induced DNA Damage
### Direct and Indirect Action
Radiation causes DNA damage through two main mechanisms: direct and indirect action. Direct action occurs when ionizing radiation directly disrupts chemical bonds within the DNA molecule itself. This mechanism is more common with high-linear energy transfer (LET) radiation such as particles and neutrons, and accounts for about one-third of the damage caused by low-LET radiation like photons and electrons. Indirect action, which accounts for approximately two-thirds of damage from low-LET radiation, involves radiation ionizing water molecules surrounding the DNA. This ionization produces free radicals, especially the hydroxyl radical (OH•), which then attack the DNA. The simplified reaction is H2O → H2O+ + e- → OH• + H+. Although hydroxyl radicals have a very short diffusion distance of about 2-3 nanometers, they are highly reactive and cause significant DNA damage.
### Types of DNA Lesions
Radiation-induced DNA damage manifests in several forms. Base damage involves oxidation, deamination, or loss of individual bases, occurring at a rate of roughly 10,000 lesions per gray (Gy) per cell. Single-strand breaks (SSBs), which disrupt one strand of the DNA backbone, occur at about 1,000 per Gy per cell. These breaks are typically repaired quickly and rarely result in cell death. Double-strand breaks (DSBs), where both strands are disrupted within a span of 10-20 base pairs, occur at approximately 40 per Gy per cell and represent the critical lethal lesion in radiation biology. DSBs are much more challenging to repair accurately, and unrepaired or misrepaired DSBs lead to chromosome aberrations and ultimately cell death. Clustered damage, or multiply damaged sites, consist of multiple lesions such as SSBs, DSBs, and base damage occurring within one to two helical turns of DNA. This type of damage is unique to ionizing radiation and is more common with high-LET radiation. Clustered damage is particularly difficult to repair and strongly correlates with cell killing.
| DNA Lesion Type | Frequency per Gy per Cell | Repair Difficulty | Clinical Significance |
|---|---|---|---|
| Base damage | ~10,000 | Easy (BER) | Rarely lethal |
| Single-strand breaks (SSBs) | ~1,000 | Easy (rapid repair) | Rarely lethal alone |
| Double-strand breaks (DSBs) | ~40 | Difficult (NHEJ, HR) | Critical lethal lesion |
| Clustered damage (multiply damaged sites) | Variable (higher with high-LET) | Very difficult | Strongly correlates with cell kill |
### Chromosome Aberrations
Misrepair of DSBs can produce chromosome aberrations that become visible during mitosis. Dicentric chromosomes, formed by the fusion of two chromosome fragments from different chromosomes, are lethal at mitosis. Other aberrations include rings, translocations, and deletions, all resulting from DSB misrepair. Asymmetric exchanges such as dicentrics and rings are lethal, whereas symmetric exchanges like translocations may allow cell survival but carry oncogenic potential. The linear-quadratic model of cell kill correlates well with the dose-response relationship observed for dicentric chromosome formation.
## DNA Repair Pathways
### Non-Homologous End Joining (NHEJ)
Non-homologous end joining is the primary pathway for repairing DSBs in mammalian cells. It is active throughout the cell cycle, including the G1 phase, and repairs the majority of DSBs within 1 to 2 hours. Although fast, NHEJ is error-prone and may introduce small deletions or insertions at the repair junction. Key proteins involved include the Ku70/Ku80 heterodimer, which recognizes broken DNA ends, DNA-PKcs (a kinase), XRCC4, Ligase IV, and XLF. Deficiencies in NHEJ components, such as DNA-PKcs, result in severe radiosensitivity, as seen in SCID mice.
### Homologous Recombination (HR)
Homologous recombination repairs DSBs using the sister chromatid as a template, ensuring accurate and error-free repair. This pathway is active only during the S and G2 phases of the cell cycle when the sister chromatid is available. Although slower than NHEJ, HR is highly accurate. The MRN complex (Mre11-Rad50-Nbs1) initiates end processing, while BRCA1, BRCA2, and RAD51 play crucial roles in strand invasion and repair. Mutations in BRCA1 or BRCA2 impair HR, leading to increased radiosensitivity and forming the basis for synthetic lethality with PARP inhibitors.
### Base Excision Repair (BER)
Base excision repair addresses single-base lesions and single-strand breaks. It involves glycosylases that remove damaged bases, APE1 which cleaves at abasic sites, DNA polymerase beta, XRCC1, and Ligase III. BER is rapid and efficient, handling the most common radiation-induced lesions.
### Mismatch Repair (MMR)
Mismatch repair corrects base mismatches and small insertion/deletion loops. Deficiencies in MMR, as seen in Lynch syndrome or microsatellite instability-high (MSI-high) tumors, may alter radiation sensitivity. The role of MMR in radiation response is complex; MMR-deficient cells may exhibit resistance to some DNA-damaging agents, but this effect is more relevant to chemotherapy than radiotherapy.
### Cell Cycle Checkpoints
Cell cycle checkpoints regulate the response to DNA damage. The G1/S checkpoint, which is p53-dependent, allows repair before DNA replication. Tumors with p53 mutations have defective G1 checkpoints and may enter S phase with unrepaired damage. The intra-S checkpoint slows replication in response to damage via the ATR/Chk1 pathway. The G2/M checkpoint prevents entry into mitosis when DSBs remain unrepaired, mediated by the ATM/Chk2 pathway. Therapeutically, G2/M checkpoint inhibitors can be combined with radiation to force damaged cells into mitosis, enhancing cell kill.
## Modes of Radiation-Induced Cell Death
### Mitotic Catastrophe
Mitotic catastrophe is the dominant mode of radiation-induced death in most solid tumor cells. Cells attempt mitosis with unrepaired chromosome damage, leading to aberrant mitosis and death during or after division. This process may take one to five cell divisions to manifest, explaining why tumor regression after radiation is often gradual.
### Apoptosis
Apoptosis is a programmed, rapid, and orderly form of cell death. It predominates in lymphoid cells and some embryonal tumors, which are highly radiosensitive. Both p53-dependent and p53-independent apoptotic pathways exist. However, most solid tumors exhibit a limited apoptotic response to radiation.
### Senescence
Senescence involves permanent growth arrest without cell death and may contribute significantly to the radiation response of some tumors. This process depends on the p53 and Rb pathways.
### Autophagy
Autophagy, or "self-eating," involves degradation of cellular components. Depending on the context, it may serve as a survival mechanism or a death pathway. It is increasingly recognized as a component of the radiation response.
## The Oxygen Effect
### Oxygen Enhancement Ratio (OER)
The oxygen enhancement ratio (OER) is defined as the ratio of the radiation dose required under hypoxic conditions to that required in air to produce the same biological effect. For low-LET radiation such as photons and electrons, the OER is approximately 2.5 to 3.0, indicating that oxygen presence significantly increases radiation effectiveness. For high-LET radiation like neutrons and heavy ions, the OER is lower, around 1.0 to 1.5. Oxygen must be present at the time of irradiation, within microseconds, to exert its radiosensitizing effect.
### Mechanism of Oxygen Fixation
The oxygen fixation hypothesis explains how oxygen enhances radiation damage. Radiation produces free radicals (R-) in DNA, which can either be fixed permanently by oxygen or repaired in the absence of oxygen. Under normoxic conditions, oxygen reacts with the free radical to form a peroxy radical (RO2-), which causes irreparable damage leading to cell death. In hypoxic conditions, sulfhydryl compounds such as glutathione donate a hydrogen atom to the free radical, restoring the DNA to its original state and allowing cell survival. The critical partial pressure of oxygen (pO2) for radiosensitization is approximately 3-5 mmHg, with full effect achieved at around 20 mmHg, which is much lower than the arterial pO2 of about 100 mmHg.
### Tumor Hypoxia
Tumor hypoxia occurs in several forms. Chronic or diffusion-limited hypoxia arises when cells are located beyond the oxygen diffusion distance of approximately 100-150 micrometers from capillaries, as described by Thomlinson and Gray in 1955. Acute or perfusion-limited hypoxia results from transient fluctuations in blood flow causing intermittent oxygen deprivation. Anemic hypoxia occurs due to reduced oxygen-carrying capacity of the blood. The hypoxic fraction refers to the proportion of clonogenic tumor cells that are hypoxic, typically around 10-20%. Even a small hypoxic fraction can dominate the radiation response because hypoxic cells are 2.5 to 3 times more resistant to radiation.
### Clinical Significance of Hypoxia
Hypoxia is a negative prognostic factor in multiple cancer types, including cervical, head and neck, and non-small cell lung cancers. Detection methods include the invasive Eppendorf electrode (historical), positron emission tomography (PET) tracers such as FMISO, FAZA, and Cu-ATSM, pimonidazole staining, and hypoxia gene signatures. Fractionated radiation therapy exploits the phenomenon of reoxygenation between fractions, which is one of the "4 Rs" of radiobiology.
### Strategies to Overcome Hypoxia
Several strategies aim to overcome hypoxia-induced radioresistance. Fractionation allows reoxygenation as tumors shrink and hypoxic cells gain access to blood supply. Hyperbaric oxygen therapy has shown benefit in some trials but is impractical for routine use. Oxygen-mimetic radiosensitizers like nimorazole have demonstrated clinical benefit, as evidenced by the DAHANCA trials, and are standard of care for head and neck cancer in Denmark, although they have not been widely adopted elsewhere. Misonidazole, another radiosensitizer, is too toxic for routine use. Hypoxia-activated prodrugs such as tirapazamine have shown disappointing results in phase III trials. Erythropoiesis-stimulating agents can correct anemia but have been shown to worsen outcomes in cancer patients and are therefore avoided. The combination of carbogen and nicotinamide (ARCON) addresses both chronic and acute hypoxia and has shown some benefit in bladder and larynx cancers. High-LET radiation modalities like neutrons and carbon ions reduce the oxygen enhancement ratio. Investigational approaches include dose escalation to hypoxic subvolumes, known as hypoxia-guided dose painting.
A molecular diagram showing the mechanism of radiation-induced DNA double-strand break and the two major repair pathways. On the left, a DNA double helix with a DSB is shown. Two arrows branch out: one leads to the NHEJ pathway (showing Ku70/80 binding to broken ends, DNA-PKcs recruitment, and Ligase IV-mediated ligation, with a small deletion at the repair site), and the other leads to the HR pathway (showing end resection, RAD51 filament formation on single-stranded DNA, strand invasion of the sister chromatid template, and error-free repair). The cell cycle phases where each pathway is active are noted.
A diagram illustrating the oxygen fixation hypothesis. A DNA molecule with a radiation-induced free radical (R-) is shown at center. On the left pathway (normoxic conditions), oxygen reacts with R- to form a peroxy radical (RO2-), which is chemically fixed and leads to permanent, irreparable damage (cell kill). On the right pathway (hypoxic conditions), a sulfhydryl donor (glutathione, GSH) donates a hydrogen atom to R-, restoring the DNA to its original state (damage repaired, cell survives).
A cross-section illustration of a solid tumor showing concentric zones around a central blood vessel. The innermost zone (well-oxygenated, pO2 > 20 mmHg) shows radiosensitive cells. The intermediate zone (diffusion-limited hypoxia, pO2 < 5 mmHg) shows radioresistant viable cells at approximately 100-150 micrometers from the vessel. The outermost zone shows necrotic tissue. The Thomlinson-Gray model is labeled, with the oxygen diffusion gradient depicted as a color gradient from red (oxygenated) to blue (hypoxic) to gray (necrotic).
## Key Clinical Pearls
The double-strand break is the critical lethal lesion caused by radiation, with approximately 40 DSBs generated per Gy per cell. Most DSBs are repaired, but it is the unrepaired or misrepaired breaks that lead to cell death. Tumors harboring BRCA1 or BRCA2 mutations have defective homologous recombination repair and are inherently more radiosensitive; this has important implications for treatment planning and the use of PARP inhibitors. The oxygen effect is one of the most significant factors limiting tumor curability with radiation, as tumors with substantial hypoxia, such as bulky head and neck or cervical cancers, have poorer outcomes. Nimorazole remains the only hypoxic radiosensitizer with proven clinical benefit and is standard of care for head and neck cancer in Denmark, although it has not been widely adopted elsewhere. Finally, most radiation-induced cell death occurs through mitotic catastrophe over several cell divisions, which explains the typical time course of tumor regression over weeks to months following radiation therapy.
## References
- Hall EJ, Giaccia AJ. *Radiobiology for the Radiologist*, 8th edition. Chapters 1-5.
- Thomlinson RH, Gray LH. "The histological structure of some human lung cancers and the possible implications for radiotherapy." *Br J Cancer*. 1955;9(4):539-549.
- Overgaard J et al. "A randomized double-blind phase III study of nimorazole as a hypoxic radiosensitizer of primary radiotherapy in supraglottic larynx and pharynx carcinoma (DAHANCA 5)." *Radiother Oncol*. 1998;46(2):135-146.
- Jackson SP, Bartek J. "The DNA-damage response in human biology and disease." *Nature*. 2009;461:1071-1078.
- Bristow RG, Hill RP. "Hypoxia and metabolism: hypoxia, DNA repair, and genetic instability." *Nat Rev Cancer*. 2008;8:180-192.